AI optimizes treatment plans for cancer patients almost immediately, limiting delays

Cancer patients are often expected to wait before starting radiation therapy so that a full treatment plan can be developed. AI could help make such delays a thing of the past, according to new research out of UT Southwestern Medical Center in Dallas, Texas.

“Some of these patients need radiation therapy immediately, but doctors often have to tell them to go home and wait,” Steve Jiang, PhD, director of UT Southwestern’s Medical Artificial Intelligence and Automation (MAIA) Lab, said in a prepared statement. “Achieving optimal treatment plans in near real time is important and part of our broader mission to use AI to improve all aspects of cancer care.”

Jiang contributed to two new studies published in Medical Physics, the official journal of the American Association of Physicists in Medicine. In one study, the authors found that AI could “produce optimal treatment plans within five-hundredths of a second after receiving clinical data for patients.” Jiang and colleagues explored data from 70 prostate cancer patients, training AI to assess each patient’s entire situation and predict the treatment plan ultimately chosen by healthcare providers.

“The real‐time prediction capabilities allow for a physician to quickly navigate the tradeoff space for a patient, and produce a dose distribution as a tangible endpoint for the dosimetrist to use for planning,” the authors wrote. “This is expected to considerably reduce the treatment planning time, allowing for clinicians to focus their efforts on the difficult and demanding cases.”

In addition, another study published in Medical Physics focused on AI’s ability to recalculate dosages before each radiation session. This represents another significant step in reducing the time it takes for cancer patients to receive the care they need.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”